Is Lemon Balm Stress Randomized Trial safe?

The current Migaku evidence database contains 2 reusable source documents for Lemon Balm Stress Randomized Trial. This answer focuses on safety, limits, and clinician-discussion contexts. - Arbuscular mycorrhizal fungi (AMF) inoculation reduced disease severity caused by F. [Saderi SZ (2026); evidence level 4] - However, higher drought levels, especially 25% pot capacity (25% PC), increased disease incidence (by 45%) compared to diseased plants without drought stress. [Saderi SZ (2026); evidence level 4] - Despite pathogen and drought stress, mycorrhizal symbiosis increased biomass production and photosynthetic pigment content in lemon balm. [Saderi SZ (2026); evidence level 4] - Melissa officinalis, commonly known as lemon balm, is vulnerable to drought stress and pathogenic diseases, including those caused by Fusarium species, which can significantly affect the plant’s growth and yield. [Saderi SZ (2026); evidence level 4] - Historical use of medicinal plants was a result of cumulative trial and error experience and the transmission of traditional knowledge between generations, which later inspired systematic efforts to turn empirical claims into evidence-based arguments []. [Cîmpeanu Ioan-Alexandru (2026); evidence level 4] Evidence levels are sorting aids, not final clinical grades. Level 1 usually indicates systematic-review style evidence, level 2 indicates randomized trials or public-health guidance, and lower levels need more cautious wording. This page is educational. People with medical conditions, pregnancy, medication use, or unusual symptoms should ask a qualified clinician before changing supplements, medication, or treatment routines.